CellGenix® rh IFN-γ (Preclinical Grade)

Tech Support
CellGenix® rh IFN-γ (Preclinical Grade)
 

  • Optimal use for maturation of monocyte-derived dendritic cells (Mo-DCs) and generation of CIKs
  • Recombinant Human Interferon-gamma
  • ADCF Level 2
  • High purity to ensure the safety of your process
  • Endotoxin Level ≤ 1000 EU/mg

Size
Quality Grade
Item No.: 
1425-050
Availability: 

*Custom/bulk order quotes are provided within 72 hours of request.

CellGenix® Preclinical Recombinant Human Interferon-gamma (IFN-γ) is an animal-derived component-free product. It is produced in a dedicated animal-free GMP facility.

IFN-γ is used in the cell and gene therapy space for the ex vivo maturation of monocyte-derived dendritic cells (Mo-DCs), ex vivo generation of cytokine induced killer cells (CIK cells) and stimulation of monocytes, macrophages and microglia.

Designed to meet the demands of translational research, CellGenix® preclinical cytokines are ideal to bridge the gap between the lower quality of research grade and the high cost of GMP grade materials.

Please access the Certificate of Analysis on the My Sartorius Portal.

Expiry: 3 years from date of shipping

Applications

  • Application
    Preclinical ex vivo use
  • Application Area
    • Cell & gene therapy
    • Immunology
  • Cell Type
    • DC
    • Neuronal Cells
  • Intended Use
    Preclinical ex vivo use

Biological Information

  • Activity
    ≥ 10 x 106 IU/mg

Compliance Information

  • Origin
    Animal-Component Free
  • Quality Grade
    Preclinical

Features

  • Carrier-Protein Free
    Yes

Physicochemical Information

  • Endotoxin
    ≤ 1 EU/µg
  • Expression System
    E. coli
  • Formulation
    Lyophilized from a 0.2 µm-filtered solution containing 20 mM succinate, pH 5.0

Product Information

  • Brand
    CellGenix®
  • Package Type
    Vial
  • Size
    50 µg

Sterility/Purity

  • Delivery Condition
    Sterile
  • Purity
    ≥ 95%

Weight

  • Molecular Weight (kDa)
    16.5 kDa